Organon & Co
XBER:7XP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Organon & Co
XBER:7XP
|
US |
|
S
|
Schumag AG
XHAM:SCM
|
DE |
|
W
|
Walgreens Boots Alliance Inc
XMUN:W8A
|
US |
|
B
|
Bayerische Motoren Werke AG
F:BMW
|
DE |
|
Korea Electric Power Corp
F:KOP
|
KR |
|
Smith & Nephew PLC
F:NPW1
|
UK |
|
V
|
Vale SA
F:CVLC
|
BR |
|
Next 15 Group PLC
F:8LS
|
UK |
|
T
|
Thor Industries Inc
F:TIV
|
US |
|
Fairvest Ltd
F:2T20
|
ZA |
|
B
|
BCE Inc
NYSE:BCE
|
CA |
|
Nordson Corp
NASDAQ:NDSN
|
US |
|
Schumag AG
F:SCM
|
DE |
|
G
|
Givaudan SA
XBER:GIN
|
CH |
|
R
|
Reach PLC
SWB:MRR
|
UK |
|
P
|
Prima Marine PCL
SET:PRM
|
TH |
|
A
|
American Tower Corp
F:A0T
|
US |
|
El Puerto de Liverpool SAB de CV
BMV:LIVEPOL1
|
MX |
|
Midea Real Estate Holding Ltd
F:MR9
|
CN |
|
M
|
Mitsubishi Kakoki Kaisha Ltd
F:893
|
JP |
|
MTN Group Ltd
F:LL6
|
ZA |
|
African Rainbow Minerals Ltd
F:EB9
|
ZA |
|
Basf Se
LSE:0BFA
|
DE |
|
Orrstown Financial Services Inc
NASDAQ:ORRF
|
US |
Bankruptcy Probability
Organon & Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Organon & Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Organon & Co
NYSE:OGN
|
3.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
670.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
376.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
247.2B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Organon & Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Organon & Co has total debt of 8.5B USD. This includes both short-term (0 USD) and long-term (8.5B USD) debt.
You can find a full breakdown on its Balance Sheet.
